Cervical cancer is still the most prevalent gynecologic malignancy and is showing a trend of rejuvenation. The main treatment options are radical radiotherapy and radical surgery. Radical surgery mainly includes traditional open surgery and laparoscopic surgery as well as robotic surgery which is not yet popular. Our department has reached the ranks of domestic advanced level in traditional surgery and minimally invasive laparoscopic surgery. Many patients have questions about why they need additional treatment after surgery, so we will explain this issue. The pathology after surgery with medium and high-risk factors requires supplemental radiotherapy or simultaneous radiotherapy: 1. Medium-risk factors: local tumor larger than 4CM, tumor emboli in the vasculature, tumor invading more than 1/2 of the cervical muscle layer. 2. High-risk factors: metastasis in the lymph nodes, tumor residue in the vaginal margin, tumor residue in the parametrial ligament. High-risk factors and tumor embolism in the vasculature require additional radiotherapy and chemotherapy after surgery. Chemotherapy is given in combination with cisplatin-based chemotherapy, generally two combinations are commonly used, and chemotherapy is given twice. Radiation therapy is given in a large field of 4500 CGY in vitro, supplemented by a reduced field of 1000 CGY to 1500 CGY, or an appropriate dose in the vaginal cavity, depending on the situation. The other two intermediate-risk factors are usually treated with external large-field radiotherapy alone. Nowadays, patients with only one intermediate risk factor are also given only 3-4 chemotherapy sessions to avoid the impact of radiotherapy on the patient’s quality of life. May all patients receive standardized, individualized, humanized and minimally invasive treatment to obtain the best outcome and quality of life.